| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:2835-2841.)
© 2007 American Heart Association, Inc.
Interventional Cardiology |
From the Division of Cardiovascular Diseases (M.S., C.S.R., B.J.G., A.P., P.S., D.R.H.) and the Division of Biostatistics (R.J.L., R.E.G.), Mayo Clinic, Rochester, Minn.
Correspondence to Mandeep Singh, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail singh.mandeep{at}mayo.edu
Received April 7, 2006; accepted April 10, 2007.
Background Little is known about the impact of technological and pharmacological advances on long-term outcome after percutaneous coronary intervention in general clinical practice.
Methods and Results We analyzed in-hospital and long-term outcome of 24 410 percutaneous coronary interventions among 18 575 unique patients who underwent percutaneous coronary intervention at Mayo Clinic over 25 years. The study population was divided into group 1 (n=3708), coronary interventions from 1979 to 1989; group 2 (n=7020), interventions from 1990 to 1996; group 3 (n=10 952), interventions from 1996 to 2003; and group 4 (n=2730), interventions from 2003 to 2004. Despite the fact that patients in groups 3 and 4 were significantly older, sicker, and had greater prevalence of comorbid conditions, heart failure, and previous revascularization than those in groups 1 and 2, procedural success in groups 3 and 4 improved significantly (94%) versus groups 2 (89%) and 1 (78%) (P<0.001). Significant reduction in in-hospital mortality (groups 4 to 1: 1.8%, 1.7%, 2.6%, 3.0%; P<0.001) and need for emergency bypass surgery (groups 4 to 1: 0.4%, 0.5%, 1.6%, 5%; P<0.001) was noted in groups 3 and 4 compared with groups 1 and 2. Better adherence to currently recommended evidence-based medications for secondary prevention was seen in the recent time periods. After adjustment, significant reduction in follow-up mortality (hazard ratio, 0.81 and 0.74 for groups 3 and 4, respectively); death or myocardial infarction (hazard ratio, 0.80 and 0.75 for groups 3 and 4, respectively); death, myocardial infarction, or revascularization (hazard ratio, 0.76 and 0.58 for groups 3 and 4, respectively) was noted in recent time periods.
Conclusions Despite higher-risk profiles of patients who underwent percutaneous coronary intervention in recent time periods, procedural success as well as in-hospital and long-term outcomes improved significantly over the last 25 years.
This article has been cited by other articles:
![]() |
M. Singh, B. J. Gersh, R. J. Lennon, H. H. Ting, D. R. Holmes Jr, B. J. Doyle, and C. S. Rihal Outcomes of a System-Wide Protocol for Elective and Nonelective Coronary Angioplasty at Sites Without On-site Surgery: The Mayo Clinic Experience Mayo Clin. Proc., June 1, 2009; 84(6): 501 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Venkitachalam, K. E. Kip, F. Selzer, R. L. Wilensky, J. Slater, S. R. Mulukutla, O. C. Marroquin, P. C. Block, D. O. Williams, S. F. Kelsey, et al. Twenty-Year Evolution of Percutaneous Coronary Intervention and Its Impact on Clinical Outcomes: A Report From the National Heart, Lung, and Blood Institute-Sponsored, Multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries Circ Cardiovasc Interv, February 1, 2009; 2(1): 6 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Singh, E. D. Peterson, M. T. Roe, F.-S. Ou, J. A. Spertus, J. S. Rumsfeld, H. V. Anderson, L. W. Klein, K. K.L. Ho, and D. R. Holmes Trends in the Association Between Age and In-Hospital Mortality After Percutaneous Coronary Intervention: National Cardiovascular Data Registry Experience Circ Cardiovasc Interv, February 1, 2009; 2(1): 20 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. From, C. S. Rihal, R. J. Lennon, D. R. Holmes Jr, and A. Prasad Temporal Trends and Improved Outcomes of Percutaneous Coronary Revascularization in Nonagenarians J. Am. Coll. Cardiol. Intv., December 1, 2008; 1(6): 692 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Rao and S. Y.H. Kim Informing the Consent Process Circ Cardiovasc Qual Outcomes, September 1, 2008; 1(1): 7 - 8. [Full Text] [PDF] |
||||
![]() |
S. V. Rao, F.-S. Ou, T. Y. Wang, M. T. Roe, R. Brindis, J. S. Rumsfeld, and E. D. Peterson Trends in the Prevalence and Outcomes of Radial and Femoral Approaches to Percutaneous Coronary Intervention: A Report From the National Cardiovascular Data Registry J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 379 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Hutchens, J. Dunlap, P. D. Hurn, and P. O. Jarnberg Renal Ischemia: Does Sex Matter? Anesth. Analg., July 1, 2008; 107(1): 239 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Dixon, C. L. Grines, and W. W. O'Neill The year in interventional cardiology. J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2355 - 2369. [Full Text] [PDF] |
||||
![]() |
P. Garg, D. J. Cohen, T. Gaziano, and L. Mauri Balancing the Risks of Restenosis and Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents: Results of a Decision Analytic Model J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1844 - 1853. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |